![](/img/cover-not-exists.png)
Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
Faiena, Izak, Cummings, Amy L, Crosetti, Anna M, Pantuck, Allan J, Chamie, Karim, Drakaki, AlexandraVolume:
Volume 12
Language:
english
Journal:
Drug Design, Development and Therapy
DOI:
10.2147/DDDT.S141491
Date:
January, 2018
File:
PDF, 724 KB
english, 2018